Author

O. T.-Y. Tsang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Organism:mouse· 1

Frequent Co-Authors

C. K. P. Mok· 2 shared G. K. Yip· 2 shared H. Lv· 2 shared I. A. Wilson· 2 shared N. C. Wu· 2 shared R. T. Y. So· 2 shared W. W. Ng· 2 shared Y. Lin· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

C. K. P. Mok

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Vaccine-breakthrough infection by the SARS-CoV-2 Omicron variant elicits broadly cross-reactive immune responses

R. Zhou, K. K.-W. To, Q. Peng, J. M.-C. Chan, H. Huang, D. Yang, B. H.-S. Lam, V. W.-M. Chuang, J.-P. Cai, N. Liu, K.-K. Au, O. T.-Y. Tsang, K.-Y. Yuen, Z. Chen

This study examines immune responses in vaccine-breakthrough Omicron infections, finding rapid cross-reactive neutralizing antibodies and T cell responses against multiple variants.

bioRxiv · Dec 27, 2021Immunology

Homologous and heterologous serological response to the N-terminal domain of SARS-CoV-2

H. Lv, O. T.-Y. Tsang, R. T. Y. So, Y. Wang, H. Liu, G. K. Yip, Q. W. Teo, Y. Lin, W. Liang, J. Wang, W. W. Ng, I. A. Wilson, M. Peiris, N. C. Wu, C. K. P. Mok

The paper examines the serological response to the N-terminal domain (NTD) of SARS-CoV-2, showing it is less cross-reactive with SARS-CoV and less effective as an immunogen compared to the RBD.

bioRxiv · Feb 17, 2021 · PreprintImmunology

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections

H. Lv, N. C. Wu, O. T.-Y. Tsang, M. Yuan, R. A. P. M. Perera, W. S. Leung, R. T. Y. So, J. M. C. Chan, G. K. Yip, T. S. H. Chik, Y. Wang, C. Y. C. Choi, Y. Lin, W. W. Ng, J. Zhao, , C. K. P. Mok

This study examines cross-reactive antibody responses between SARS-CoV-2 and SARS-CoV, finding common binding but rare neutralization, suggesting non-neutralizing antibodies target conserved epitopes.

bioRxiv · Mar 15, 2020Microbiology